| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Biological immunomodulators
|
Hasler, Paul
|
|
2006
|
27 |
4 |
p. 389-390
|
article
|
| 2 |
Biological therapies directed against cells in autoimmune disease
|
Hasler, Paul
|
|
2006
|
27 |
4 |
p. 443-456
|
article
|
| 3 |
Biologics in the prevention and treatment of graft rejection
|
Marks, Reinhard
|
|
2006
|
27 |
4 |
p. 457-476
|
article
|
| 4 |
Complement C2 receptor inhibitor trispanning: from man to schistosome
|
Inal, Jameel M.
|
|
2006
|
27 |
4 |
p. 509-510
|
article
|
| 5 |
Disturbances in placental immunology: ready for therapeutic interventions?
|
Hahn, Sinuhe
|
|
2006
|
27 |
4 |
p. 477-493
|
article
|
| 6 |
Hereditary auto-inflammatory disorders and biologics
|
Church, Leigh D.
|
|
2006
|
27 |
4 |
p. 494-508
|
article
|
| 7 |
Inhibition of IL-1, IL-6, and TNF-α in immune-mediated inflammatory diseases
|
Möller, Burkhard
|
|
2006
|
27 |
4 |
p. 391-408
|
article
|
| 8 |
Interleukin-12 to interleukin ‘infinity’: the rationale for future therapeutic cytokine targeting
|
Anderson, E. J. R.
|
|
|
27 |
4 |
p. 425-442
|
article
|
| 9 |
Interleukin-12 to interleukin ‘infinity’: the rationale for future therapeutic cytokine targeting
|
Anderson, E. J. R.
|
|
2006
|
27 |
4 |
p. 425-442
|
article
|
| 10 |
Modification of accessory molecule signaling
|
Crow, Mary K.
|
|
2006
|
27 |
4 |
p. 409-424
|
article
|
Journal description